Skip to main content

Heron Therapeutics, Inc.

HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000818033

No open-market purchases or sales by Heron Therapeutics, Inc. insiders were filed in the last 90 days; 163 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.

Holders of 5% or more of HRTX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Heron Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of HRTX
HolderLatest formStakeChangeFirst filedLatest filingFiling
Rubric Capital Management LP13D/A15.90%30.0M shares−1.60 ppfrom 17.50%Feb 6, 20236 filingsOct 17, 2025SEC
Clearline Capital LP13G/A6.70%12.2M shares+1.40 ppfrom 5.30%Nov 26, 20252 filingsFeb 17, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

51 Schedule 13D and 13G filings on Heron Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on HRTX
Filed (ET)FilerFormStakeChangeEvent dateFiling
May 13, 20269:05 AM ETAdage Capital Management, L.P.and 2 others13G/A0.00%0 shares–Below 5%Mar 31, 2026SEC
Mar 27, 20269:30 AM ETVanguard Group Inc13G/A0.00%0 shares−5.35 ppfrom 5.35%Below 5%Mar 13, 2026SEC
Feb 17, 20262:40 PM ETClearline Capital LPand 2 others13G/A6.70%12.2M shares+1.40 ppfrom 5.30%Dec 31, 2025SEC
Jan 30, 20262:20 PM ETVanguard Group Inc13G5.35%9.82M shares+0.74 ppfrom 4.61%Dec 31, 2025SEC
Nov 26, 202510:15 AM ETClearline Capital LPand 2 others13G5.30%9.71M sharesNewSep 30, 2025SEC
Oct 30, 20253:16 PM ETVanguard Group Inc13G/A4.61%8.46M shares–Below 5%Sep 30, 2025SEC
Oct 17, 20256:02 PM ETRubric Capital Management LPand 1 other13D/A15.90%30.0M shares−1.60 ppfrom 17.50%Oct 15, 2025SEC
Aug 12, 20256:00 PM ETRubric Capital Management LPand 1 other13D/A17.50%29.1M shares–Aug 8, 2025SEC
Nov 12, 2024Adage Capital Management, L.P.13GOld format–New–SEC
Nov 8, 2024BlackRock, Inc.13GOld format–––SEC
Oct 24, 2024BlackRock, Inc.13GOld format–New–SEC
May 31, 2024Rubric Capital Management LP13D/AOld format–––SEC
Feb 14, 2024Great Point Partners LLC13G/AOld format–––SEC
Feb 14, 2024Deep Track Capital, LP13G/AOld format–––SEC
Feb 14, 2024Baker Bros. Advisors LP13G/AOld format–––SEC
Feb 13, 2024Vanguard Group Inc13G/AOld format–––SEC
Feb 6, 2024Franklin Resources Inc13G/AOld format–––SEC
Dec 7, 2023JPMorgan Chase & Co13G/AOld format–––SEC
Dec 6, 20234:47 PM ETBlackRock Inc.13G/AOld format–––SEC
Jul 25, 2023Rubric Capital Management LP13D/AOld format–––SEC
Apr 13, 2023Great Point Partners LLC13GOld format–New–SEC
Feb 22, 2023Rubric Capital Management LP13D/AOld format–––SEC
Feb 15, 2023ArrowMark Colorado Holdings LLC13G/AOld format–––SEC
Feb 14, 2023Tang Capital Partners LP13G/AOld format–––SEC
Feb 13, 2023UBS Oconnor LLC13G/AOld format–––SEC
Feb 9, 2023Vanguard Group Inc13G/AOld format–––SEC
Feb 6, 2023Rubric Capital Management LP13DOld format–New–SEC
Feb 3, 20234:27 PM ETBlackRock Inc.13G/AOld format–––SEC
Jan 31, 2023Franklin Resources Inc13G/AOld format–––SEC
Jan 23, 2023JPMorgan Chase & Co13G/AOld format–––SEC
Jan 10, 2023State Street Corp13G/AOld format–––SEC
Aug 19, 2022Deep Track Capital, LP13GOld format–New–SEC
Apr 11, 2022State Street Corp13G/AOld format–––SEC
Feb 14, 2022Tang Capital Partners LP13G/AOld format–––SEC
Feb 14, 2022UBS Oconnor LLC13GOld format–New–SEC
Feb 14, 2022ArrowMark Colorado Holdings LLC13G/AOld format–––SEC
Feb 14, 2022Baker Bros. Advisors LP13G/AOld format–––SEC
Feb 11, 2022State Street Corp13GOld format–New–SEC
Feb 10, 2022Vanguard Group Inc13G/AOld format–––SEC
Feb 4, 2022Wellington Management Group LLP13G/AOld format–––SEC
Feb 3, 2022Franklin Resources Inc13G/AOld format–––SEC
Feb 1, 20225:08 PM ETBlackRock Inc.13G/AOld format–––SEC
Jan 24, 2022JPMorgan Chase & Co13GOld format–New–SEC
Feb 16, 2021Tang Capital Partners LP13G/AOld format–––SEC
Feb 16, 2021ArrowMark Colorado Holdings LLC13GOld format–New–SEC
Feb 16, 2021Baker Bros. Advisors LP13G/AOld format–––SEC
Feb 11, 2021Janus Henderson Group PLC13G/AOld format–––SEC
Feb 10, 2021Vanguard Group Inc13G/AOld format–––SEC
Feb 4, 2021Wellington Management Group LLP13G/AOld format–––SEC
Feb 1, 2021Franklin Resources Inc13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Heron Therapeutics, Inc. shares.

No Form 144 notices for Heron Therapeutics, Inc. are on file.